Envestnet Asset Management
ZYME icon

Envestnet Asset Management’s Zymeworks ZYME Stock Holding History

Envestnet Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Sell
40,419
-393
-1% -$9.3K ﹤0.01% 3466
2025
Q4 		$1.07M Buy
40,812
+26,238
+180% +$572K ﹤0.01% 3223
2025
Q3 		$249K Sell
14,574
-32
-0.2% -$458 ﹤0.01% 4190
2025
Q2 		$183K Sell
14,606
-34,906
-71% -$416K ﹤0.01% 4256
2025
Q1 		$590K Sell
49,512
-4,578
-8% -$62.4K ﹤0.01% 3524
2024
Q4 		$792K Sell
54,090
-11,588
-18% -$162K ﹤0.01% 3314
2024
Q3 		$824K Buy
65,678
+2,994
+5% +$32.6K ﹤0.01% 3241
2024
Q2 		$533K Sell
62,684
-3,225
-5% -$28.7K ﹤0.01% 3420
2024
Q1 		$693K Buy
65,909
+16,149
+32% +$179K ﹤0.01% 3251
2023
Q4 		$517K Buy
49,760
+8,066
+19% +$64.3K ﹤0.01% 3312
2023
Q3 		$264K Buy
41,694
+12,689
+44% +$93.7K ﹤0.01% 3603
2023
Q2 		$251K Buy
29,005
+3,322
+13% +$29.7K ﹤0.01% 3579
2023
Q1 		$232K Sell
25,683
-30,482
-54% -$266K ﹤0.01% 3582
2022
Q4 		$441K Buy
+56,165
New +$395K ﹤0.01% 3166
2022
Q3 		– Sell
-11,614
Closed -$62K – 4058
2022
Q2 		$62K Buy
+11,614
New +$70.2K ﹤0.01% 3800

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Envestnet Asset Management's ZYME Position: Q1 2026 in Review

Envestnet Asset Management reduced its Zymeworks (ZYME) stake by 0.96% in Q1 2026, selling an estimated $9.3K and leaving 40,419 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #3466.

Envestnet Asset Management first reported a position in ZYME in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.07M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Envestnet Asset Management held 40,419 shares of Zymeworks worth $1.01M as of Q1 2026.
  • Envestnet Asset Management sold 393 Zymeworks shares in Q1 2026, an estimated $9.3K.
  • Zymeworks made up ﹤0.01% of Envestnet Asset Management's portfolio in Q1 2026, its #3466 holding.
  • Envestnet Asset Management first reported a position in Zymeworks in Q2 2022 and has held it in 15 quarters since.
  • Envestnet Asset Management's Zymeworks position peaked at $1.07M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.